Today's Change
+0%
AI Sentiment
55%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0% today with neutral sentiment across 5 recent news articles.
Bullish Factors
- Predominantly positive news flow
Risk Factors
- No strong bearish signals detected
Stocks in Materials
0 stocks| Symbol | Company | Change |
|---|
Materials News
926 articlesGlobeNewswire Inc.89d ago
[Latest] Global Compostable Flexible Packaging Market Size/Share Worth USD 5.18 Billion by 2035 at a 12.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Benzinga89d ago
Ionis Pharmaceuticals Repriced Drug Ahead Of Key FDA Decision Signals Push Into Larger Market
Benzinga89d ago
Securities Fraud Investigation Into ADMA Biologics, Inc. (ADMA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
GlobeNewswire Inc.89d ago
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Benzinga89d ago
Securities Fraud Investigation Into Coty Inc. (COTY) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
The Motley Fool89d ago
Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year
GlobeNewswire Inc.89d ago
Bronstein, Gewirtz & Grossman LLC Urges Atara Biotherapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
The Motley Fool89d ago
Apogee CEO Sells 20,000 Shares as Stock Surges Nearly 100% in a Year, but Here's What Really Matters for Investors
GlobeNewswire Inc.89d ago
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors
GlobeNewswire Inc.89d ago
Portnoy Law Firm Announces Class Action on Behalf of Soleno Therapeutics, Inc. Investors
Benzinga89d ago
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
Benzinga89d ago
Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
Market Sentiment
Neutral
55% Sentiment Score
Sector Stats
Total Stocks0
News Today5
Avg Volume0
AI SentimentNeutral